X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medical and health sciences (100) 100
medicin och hälsovetenskap (100) 100
humans (46) 46
clinical medicine (45) 45
klinisk medicin (45) 45
index medicus (43) 43
immunotherapy (39) 39
medicine (35) 35
immunology (34) 34
cancer and oncology (31) 31
cancer och onkologi (31) 31
animals (30) 30
medicin (30) 30
oncology (30) 30
basic medicine (25) 25
cancer (25) 25
medicinska och farmaceutiska grundvetenskaper (25) 25
mice (24) 24
female (22) 22
male (21) 21
medicine, research & experimental (21) 21
mice, inbred c57bl (20) 20
gene therapy (19) 19
hematology (17) 17
immunologi inom det medicinska området (17) 17
immunology in the medical area (17) 17
cd40 ligand - genetics (16) 16
cell line, tumor (16) 16
t cells (16) 16
chemistry (14) 14
dendritic cells (14) 14
human necessities (14) 14
hygiene (14) 14
medical or veterinary science (14) 14
metallurgy (14) 14
organic chemistry (14) 14
peptides (14) 14
preparations for medical, dental, or toilet purposes (14) 14
adenoviridae - genetics (13) 13
biotechnology & applied microbiology (13) 13
flow cytometry (13) 13
tumors (12) 12
apoptosis (11) 11
care and treatment (11) 11
chronic lymphocytic-leukemia (11) 11
genetics & heredity (11) 11
hematologi (11) 11
immunologi (11) 11
in-vivo (11) 11
middle aged (11) 11
research (11) 11
urinary bladder neoplasms - immunology (11) 11
adult (10) 10
microbiology (10) 10
t-lymphocytes, regulatory - immunology (10) 10
therapy (10) 10
urinary bladder neoplasms - therapy (10) 10
adenovirus (9) 9
beer (9) 9
biochemistry (9) 9
bladder-cancer (9) 9
cytokines (9) 9
enzymology (9) 9
genetic therapy - methods (9) 9
medical biotechnology (9) 9
medicinsk bioteknologi (9) 9
mutation or genetic engineering (9) 9
spirits (9) 9
suppressor-cells (9) 9
t regulatory cells (9) 9
t-lymphocytes - immunology (9) 9
vinegar (9) 9
wine (9) 9
aged (8) 8
antitumor immunity (8) 8
cd40 ligand - immunology (8) 8
cd40l (8) 8
genetic vectors (8) 8
lymphocytes (8) 8
medical biotechnology, molecular biology, microbiology, biochemistry or biopharmacy (8) 8
medicinsk bioteknologi, molekylärbiologi, mikrobiologi, biokemi eller biofarmaci (8) 8
multiple sclerosis (8) 8
regulatory t-cells (8) 8
activation (7) 7
adcd40l (7) 7
cancer-patients (7) 7
cd40 ligand (7) 7
compositions thereof (7) 7
culture media (7) 7
expression (7) 7
genetic therapy (7) 7
lymphocytes t (7) 7
microorganisms or enzymes (7) 7
neurology (7) 7
propagating, preserving or maintaining microorganisms (7) 7
adenoviruses (6) 6
adoptive immunotherapy (6) 6
biochemistry & molecular biology (6) 6
bladder cancer (6) 6
carcinoma (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2013, Volume 8, Issue 1, p. e55818
Immunotherapy (eg interferon alpha) in combination with tyrosine kinase inhibitors is currently in clinical trials for treatment of chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | CANCER-PATIENTS | B7-H1 PD-L1 | TUMOR BURDEN | MULTIDISCIPLINARY SCIENCES | HEPATOCELLULAR-CARCINOMA PATIENTS | IMATINIB | INTERLEUKIN-2 RECEPTOR | PHASE-I | T-CELLS | CLINICAL-SIGNIFICANCE | Antigens, CD34 - metabolism | Humans | Middle Aged | Arginase - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Young Adult | Lymphocyte Activation - immunology | T-Lymphocytes - metabolism | Myeloid Cells - immunology | Adult | Female | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology | Interleukin-2 Receptor alpha Subunit - blood | Programmed Cell Death 1 Receptor - metabolism | Gene Expression Regulation, Leukemic | B7-H1 Antigen - metabolism | Interleukin-2 Receptor alpha Subunit - metabolism | Adolescent | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Myeloid Cells - metabolism | T-Lymphocytes - immunology | Aged | Programmed Cell Death 1 Receptor - genetics | Medical research | Care and treatment | Immunotherapy | Medicine, Experimental | Development and progression | Interferon | Chronic myeloid leukemia | T cells | Risk factors | Cancer | Cell proliferation | Disease | PD-1 protein | Laboratories | Leukemia | Science | Clinical trials | Risk | Arginase | Lymphocytes T | Kinases | Suppressor cells | Ethics | Immunology | Interleukin 2 | Lymphocytes | Cell cycle | CD25 antigen | Protein-tyrosine kinase | Immune system | Tyrosine | CD34 antigen | Myeloid cells | Cytokines | Hematology | Secretion | Myeloid leukemia | Mortality | Blood banks | Patients | Studies | Pathology | Hospitals | Medical prognosis | PD-L1 protein | Stem cells | Ligands | Death | Lymphomas | Apoptosis | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Human Gene Therapy, ISSN 1043-0342, 08/2015, Volume 26, Issue 8, pp. 498 - 505
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 05/2012, Volume 9, Issue 1, pp. 112 - 112
Background: Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). In the murine experimental autoimmune encephalomyelitis (EAE)... 
EAE | Redirected cells | FoxP3 | Myelin oligodendrocyte glycoprotein (MOG) | T regulatory cells | MS | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | STEM-CELLS | TGF-BETA | redirected cells | TOLERANCE | NEUROSCIENCES | CUTTING EDGE | MYELIN OLIGODENDROCYTE GLYCOPROTEIN | MULTIPLE-SCLEROSIS | CENTRAL-NERVOUS-SYSTEM | GENE-THERAPY | T-Lymphocytes, Regulatory - metabolism | Central Nervous System - metabolism | Genetic Vectors - administration & dosage | Lentivirus - immunology | Encephalomyelitis, Autoimmune, Experimental - immunology | Central Nervous System - immunology | T-Lymphocytes, Regulatory - immunology | Cell Engineering - methods | Female | Lentivirus - genetics | Encephalomyelitis, Autoimmune, Experimental - genetics | Cell Line | Gene Transfer Techniques | Genetic Vectors - immunology | Mice, Inbred C57BL | Forkhead Transcription Factors - genetics | Administration, Intranasal | Encephalomyelitis, Autoimmune, Experimental - therapy | Animals | Receptors, Antigen, T-Cell - administration & dosage | Mice | Receptors, Antigen, T-Cell - genetics | T-Lymphocytes, Regulatory - transplantation | Forkhead Transcription Factors - administration & dosage | Genetic Therapy - methods | Animal experimentation | Antigens | Medical equipment and supplies industry | Multiple sclerosis | Medical test kit industry | Central nervous system | T cells | Gene mutations | Genetically modified organisms | Genetic engineering | Cellular signal transduction | Myelin proteins | Clinical Medicine | Neurology | Neurologi | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | myelin oligodendrocyte glycoprotein
Journal Article
Acta Neurologica Scandinavica, ISSN 0001-6314, 08/2014, Volume 130, Issue 2, pp. 81 - 89
Journal Article
Immunology, ISSN 0019-2805, 04/2012, Volume 135, Issue 4, pp. 255 - 260
Journal Article
Cancer Gene Therapy, ISSN 0929-1903, 07/2013, Volume 20, Issue 7, pp. 386 - 393
B-cell malignancies upregulate the B-cell lymphoma 2 (Bcl-2) family inhibitors of the intrinsic apoptosis pathway, making them therapy resistant. However,... 
Bcl-2 | ABT-737 | Pre-B-ALL | CAR | BH3 mimetics | Engineered T cells | MEDICINE, RESEARCH & EXPERIMENTAL | pre-B-ALL | MCL-1 | ESTABLISHMENT | CANCER | CULTURE | LINES | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | IN-VIVO | GENETICS & HEREDITY | RESISTANCE | engineered T cells | TARGETS | PROTEINS | Apoptosis - drug effects | Coculture Techniques | Humans | fas Receptor - metabolism | Recombinant Fusion Proteins - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy | Biphenyl Compounds - pharmacology | Nitrophenols - pharmacology | T-Lymphocytes - metabolism | Immunotherapy | Antineoplastic Agents - pharmacology | Antigens, CD19 - immunology | Gene Expression | Receptors, Antigen, T-Cell - metabolism | Combined Modality Therapy | HLA Antigens - metabolism | Sulfonamides - pharmacology | Piperazines - pharmacology | B7-2 Antigen - metabolism | Intercellular Adhesion Molecule-1 - metabolism | Phenotype | Cell Line, Tumor | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | T-Lymphocytes - immunology | Proto-Oncogene Proteins c-bcl-2 - genetics | Cytotoxicity, Immunologic | Antigen receptors, T cell | Care and treatment | Receptors | Research | B cells | Gene therapy | Properties | T cells | Methods | Cancer | Apoptosis | Acute lymphatic leukemia | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2010, Volume 16, Issue 12, pp. 3279 - 3287
Journal Article
Immunology, ISSN 0019-2805, 07/2014, Volume 142, Issue 3, pp. 431 - 441
Journal Article
Immunology, ISSN 0019-2805, 11/2010, Volume 131, Issue 3, pp. 371 - 376
P>Interleukin-2 (IL-2) is one of the most studied cytokines driving T-cell proliferation, activation and survival. It binds to the IL-2 receptor consisting of... 
T regulatory cell | CD25 | Interleukin-2 receptor α | Immune escape mechanism | B-cell malignancy | INTERLEUKIN-2-RECEPTOR | TUMOR | RECEPTOR | IL-2 | LEVEL | IMMUNOLOGY | CANCER | interleukin-2 receptor alpha | NON-HODGKINS-LYMPHOMA | immune escape mechanism | T-Lymphocyte Subsets - immunology | Tumor Escape - drug effects | T-Lymphocytes, Regulatory - metabolism | Lymphoma, B-Cell - blood | Humans | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Flow Cytometry | Interleukin-2 Receptor alpha Subunit - genetics | Lymphoma, B-Cell - immunology | Interleukin-2 Receptor alpha Subunit - immunology | Tumor Escape - immunology | Recombinant Proteins - metabolism | Forkhead Transcription Factors - biosynthesis | Enzyme-Linked Immunosorbent Assay | Interleukin-2 Receptor alpha Subunit - blood | Cell Separation | Cells, Cultured | Recombinant Proteins - genetics | T-Lymphocyte Subsets - pathology | Interleukin-2 Receptor alpha Subunit - metabolism | Recombinant Proteins - immunology | T-Lymphocyte Subsets - metabolism | Lymphoma, B-Cell - pathology | Cell Proliferation - drug effects | Care and treatment | Non-Hodgkin's lymphomas | T cells | Enzyme-linked immunosorbent assay | Cancer | Cell growth | Medical prognosis | T cell receptors | Original | interleukin-2 receptor α | Immunologi | Immunology | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article